Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

The observations are mainly procedural and do not indicate any data integrity issues, Piramal Pharma added in a regulatory ...

Piramal Pharma's Turbhe facility in Navi Mumbai receives six observations from U.S. FDA inspection, company preparing detailed response.

The company's Q3FY25 consolidated profit plunged 63.6 percent to Rs 3.68 crore versus Rs 10.1 crore, while revenue rose 12.5 ...

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

A fire erupted at Navi Mumbai’s Turbhe dumping ground on Tuesday, sending thick smoke into the air. Firefighters worked to ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

A fire erupted in a Navi Mumbai dumping yard, with no casualties reported. Firefighters are working to control the blaze, ...

Mumbai: A massive fire breaks out in Navi Mumbai on Tuesday. The blaze erupted at a dumping ground in Navi Mumbai's Turbhe in ...

T he labour ward of Mother and Child Hospital (MCH) in Turbhe by Navi Mumbai Municipal Corporation (NMMC) has been non-functional since over a year due to which the pregnant women in Turbhe ward ...

The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity.